DK212580A - PROCEDURE FOR PREPARING AN INFLUENZA VIRUM VACCINE IN A LIQUID CELL CULTURE - Google Patents

PROCEDURE FOR PREPARING AN INFLUENZA VIRUM VACCINE IN A LIQUID CELL CULTURE

Info

Publication number
DK212580A
DK212580A DK212580A DK212580A DK212580A DK 212580 A DK212580 A DK 212580A DK 212580 A DK212580 A DK 212580A DK 212580 A DK212580 A DK 212580A DK 212580 A DK212580 A DK 212580A
Authority
DK
Denmark
Prior art keywords
virum
influenza
vaccine
preparing
procedure
Prior art date
Application number
DK212580A
Other languages
Danish (da)
Other versions
DK154749B (en
DK154749C (en
Inventor
K K Brown
R C Stewart
Original Assignee
Cutter Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21904398&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK212580(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cutter Lab filed Critical Cutter Lab
Publication of DK212580A publication Critical patent/DK212580A/en
Publication of DK154749B publication Critical patent/DK154749B/en
Application granted granted Critical
Publication of DK154749C publication Critical patent/DK154749C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK212580A 1979-05-15 1980-05-14 PROCEDURE FOR PREPARING AN INFLUENZA VIRUS VACCINE IN A LIQUID CELL CULTURE DK154749C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3923679A 1979-05-15 1979-05-15
US3923679 1979-05-15

Publications (3)

Publication Number Publication Date
DK212580A true DK212580A (en) 1980-11-16
DK154749B DK154749B (en) 1988-12-19
DK154749C DK154749C (en) 1989-05-16

Family

ID=21904398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK212580A DK154749C (en) 1979-05-15 1980-05-14 PROCEDURE FOR PREPARING AN INFLUENZA VIRUS VACCINE IN A LIQUID CELL CULTURE

Country Status (13)

Country Link
EP (1) EP0019218B2 (en)
JP (1) JPS55153723A (en)
AR (1) AR220838A1 (en)
AT (1) ATE16454T1 (en)
AU (1) AU535804B2 (en)
CA (1) CA1122527A (en)
DE (1) DE3071225D1 (en)
DK (1) DK154749C (en)
ES (1) ES491517A0 (en)
IL (1) IL60063A0 (en)
NO (1) NO801443L (en)
RO (1) RO79525B (en)
YU (1) YU41923B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2290053A1 (en) * 1994-11-10 2011-03-02 Baxter Healthcare S.A. Method for producing Influenza virus in protein-free cell culture medium
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
AU694592B2 (en) * 1994-11-16 1998-07-23 St. Jude Children's Research Hospital Novel replication process
DE19612967A1 (en) * 1996-04-01 1997-10-02 Behringwerke Ag Process for the propagation of influenza viruses in cell culture, and the influenza viruses obtainable by the process
DE19612966B4 (en) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK cells and methods of propagating influenza viruses
DE10144906B4 (en) * 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Process for the large-scale production of vaccines
US6830917B2 (en) * 2001-12-10 2004-12-14 Baxter Healthcare S.A. Method of isolation and purification of trypsin from pronase protease and use thereof
JP2008519042A (en) 2004-11-03 2008-06-05 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド Influenza vaccination
US7883844B2 (en) 2006-05-11 2011-02-08 Juridical Foundation The Chemosero-Therapeutic Research Institute Method for propagating influenza virus
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
TW201012930A (en) * 2008-06-16 2010-04-01 Intervet Int Bv Method of replicating viruses in suspension
PL2396032T3 (en) 2009-02-10 2017-05-31 Seqirus UK Limited Influenza vaccines with reduced amounts of squalene

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262962B1 (en) * 1974-03-05 1977-11-04 Science Union & Cie

Also Published As

Publication number Publication date
YU41923B (en) 1988-02-29
YU126580A (en) 1983-12-31
EP0019218A2 (en) 1980-11-26
AU535804B2 (en) 1984-04-05
AU5824480A (en) 1980-11-20
AR220838A1 (en) 1980-11-28
EP0019218B1 (en) 1985-11-13
CA1122527A (en) 1982-04-27
JPH0124769B2 (en) 1989-05-15
RO79525B (en) 1984-09-30
JPS55153723A (en) 1980-11-29
EP0019218B2 (en) 1995-03-01
ES8104405A1 (en) 1981-04-01
DK154749B (en) 1988-12-19
IL60063A0 (en) 1980-07-31
DE3071225D1 (en) 1985-12-19
RO79525A (en) 1984-07-17
DK154749C (en) 1989-05-16
EP0019218A3 (en) 1981-03-25
NO801443L (en) 1980-11-17
ATE16454T1 (en) 1985-11-15
ES491517A0 (en) 1981-04-01

Similar Documents

Publication Publication Date Title
DK154539C (en) PROCEDURE FOR PREPARING CYCLOSPOR-CONTAINING PHARMACEUTICAL PREPARATIONS IN LIQUID FORM
DK223976A (en) CELL CULTURE PROCEDURE
DK344478A (en) PROCEDURE FOR PREPARING LIPOSOMES IN AQUATIC SOLUTION
DK54879A (en) PROCEDURE FOR PREPARING PYRIMIDONES
DK457779A (en) PROCEDURE FOR PREPARING 4-HYDROXY-2-PYRONE DERIVATIVES
DK153440C (en) PROCEDURE FOR PREPARING A NATIONAL PHARMACEUTICAL ERGOTPEPTIDALKALOID PREPARATION
DK212580A (en) PROCEDURE FOR PREPARING AN INFLUENZA VIRUM VACCINE IN A LIQUID CELL CULTURE
DK364579A (en) METHOD FOR PREPARING N2-ARYLSULPHONYL-L-ARGINIAMIDS
DK19579A (en) PROCEDURE FOR PREPARING SPIROTHIENH HYDANTO INTERVENTIVES
DK155915C (en) PROCEDURE FOR PREPARING PERTUSSIS TOXOID FOR USE IN VACCINES
DK294880A (en) PROCEDURE FOR PREPARING N-PHOSPHONOMETHYLGYLINE
DK152218C (en) POROEST, SQUARE GEL MATERIAL FOR SEPARATION FORM AND PROCEDURE FOR PREPARING THE SAME AND USING IT TO MAKE A MODIFIED POROEST GEL MATERIAL
DK476180A (en) PROCEDURES FOR PREPARING TABLETS
DK148981C (en) PROCEDURE FOR PREPARING AN IMMOBILIZED ENZYME PREPARATION
DK396880A (en) PROCEDURE FOR PREPARING CYCLOHEXANCARBOXYLIC ACID DERIVATIVES
DK138879A (en) PROCEDURE FOR PREPARING LYSERGOLD DERIVATIVES
DK7679A (en) PROCEDURE FOR PREPARING A PROSTAGLAND-CONTAINING PREPARATION
DK517979A (en) PROCEDURE FOR PREPARING ALCOHOL
DK165687C (en) METHOD FOR PREPARING 2-CHLOROSULPHINYLZETIDINONES
DK150479C (en) METHOD FOR PREPARING 2-CHLOR-5-TRIFLUORMETHYLPYRIDINE
DK377679A (en) PROCEDURE FOR IMPROVING THE HARDNESS OF A BACTERY CELL UNIT
DK177680A (en) PROCEDURE FOR PREPARING 7-N-HETEROCYCLYL-CEPHALOSPORINES
DK197477A (en) PROCEDURE FOR PREPARING A LIPASE-RICH ENZYME PREPARATION
DK67380A (en) PROCEDURE FOR PREPARING 7-ACYL-INDOLIN-2-ONES
DK569078A (en) PROCEDURE FOR PREPARING NEW ARYLAMINOIMIDAZOLINE DERIVATIVES

Legal Events

Date Code Title Description
PUP Patent expired